Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

The Development of Nitric Oxide Donor Drugs as Targeted Anti-Cancer Therapeutics

A postgraduate research opportunity at the University of Otago.

Details

Close date
Saturday, 30 November 2019
Academic background
Sciences, Health Sciences
Host campus
Dunedin
Location
On-campus
Qualifications
PhD, Master’s
Department
Pharmacology and Toxicology
Supervisor
Dr Gregory Giles

Overview

Nitric oxide is a potent signalling molecule involved in the regulation of the cardiovascular system, neurotransmission, and the immune response. We are developing new nitric oxide releasing drugs to combat a range of diseases, with a focus on cancer therapy. Opportunities exist for students interested in synthetic approaches to drug discovery, drug formulation, and the analysis of drug mechanism-of-action, to join our multi-disciplinary team to help develop these new therapeutic agents towards clinical trials. Successful applicants will train in a drug discovery programme that provides a pathway into a career in the pharmaceutical sector, and candidates with a background in chemistry, biochemistry, or pharmacology, are strongly encouraged to apply.

Contact

Dr Gregory Giles
Tel   +64 3 479 7322
Email   gregory.giles@otago.ac.nz